Group One Trading’s Intersect ENT, Inc XENT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-14,086
Closed -$395K 8917
2022
Q1
$395K Buy
14,086
+10,100
+253% +$277K ﹤0.01% 4065
2021
Q4
$109K Sell
3,986
-8,794
-69% -$238K ﹤0.01% 5664
2021
Q3
$348K Buy
12,780
+7,629
+148% +$189K ﹤0.01% 4589
2021
Q2
$88K Buy
+5,151
New +$96.4K ﹤0.01% 6091
2021
Q1
Sell
-4,116
Closed -$95K 8217
2020
Q4
$94K Buy
+4,116
New +$78.4K ﹤0.01% 4617
2020
Q2
Sell
-27,682
Closed -$322K 6387
2020
Q1
$328K Buy
+27,682
New +$614K ﹤0.01% 2364
2019
Q2
Sell
-15,339
Closed -$414K 5591
2019
Q1
$493K Sell
15,339
-10,409
-40% -$322K 0.01% 1951
2018
Q4
$726K Sell
25,748
-2,145
-8% -$62.8K 0.01% 1735
2018
Q3
$802K Buy
+27,893
New +$838K 0.01% 1880
2018
Q2
Sell
-300
Closed -$11.8K 5627
2018
Q1
$12K Sell
300
-400
-57% -$14.6K ﹤0.01% 4272
2017
Q4
$23K Buy
+700
New +$21K ﹤0.01% 4105
2017
Q1
Sell
-2,900
Closed -$35K 5154
2016
Q4
$35K Buy
2,900
+2,500
+625% +$32.4K ﹤0.01% 3461
2016
Q3
$6K Buy
+400
New +$6.02K ﹤0.01% 4185

Group One Trading's XENT Position: Q2 2022 in Review

Group One Trading sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 14,086 shares — an estimated $395K sold.

Group One Trading first reported a position in XENT in Q3 2016 and held it in 13 quarters. The position peaked at $802K in Q3 2018. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.

  • Group One Trading reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
  • Group One Trading sold 14,086 Intersect ENT, Inc shares in Q2 2022, an estimated $395K.
  • Group One Trading first reported a position in Intersect ENT, Inc in Q3 2016 and held it in 13 quarters.
  • Group One Trading's Intersect ENT, Inc position peaked at $802K in Q3 2018.
  • 0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.

Based on Group One Trading's 13F filing for Q2 2022, filed 11 Aug 2022.